Goldman Sachs commodity analysts are sticking to their forecast for Brent to average $59 a barrel by the fourth quarter of this year and $56 in 2026, following a bigger-than-expected production rise ...

Jaiprakash Power Ventures, BSE, Dixon Tech, Godrej Consumer Products, PC Jeweller, HDFC Bank, Trent, Bharat Electronics, ...

Eli Lilly has outpaced Ozempic-maker Novo Nordisk in the race to develop new incretin drugs.The company is set to capture 50% of the $95 billion obesity market by 2050.We got a glimpse into Eli ...